Study Examines Early Immune System Targets in Scleroderma

Study Examines Early Immune System Targets in Scleroderma: "As is the case with most diseases, the best chance of treatment success with scleroderma is early in the process of the disease, before it has had the chance to cause irreparable damage. If doctors knew what started scleroderma – the initial targets of self-directed antibodies that seem to set the disease in motion – they might be able to diagnose it earlier and begin treatment earlier with specifically targeted therapies, says Judith James, M.D., Ph.D., Lou Kerr Chair in Biomedical Research and professor of medicine at University of Oklahoma Health Sciences Center."